ImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors [Yahoo! Finance]
Hologic, Inc. (HOLX)
Last hologic, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.hologic.com
Company Research
Source: Yahoo! Finance
CARLSBAD, Calif. Feb. 25, 2026 /PRNewswire/ -- ImpediMed , a leader in the development and commercialization of medical technologies to clinically monitor and manage fluid and body composition, today announced the appointment of Erik Anderson to its Board of Directors. ImpediMed is a medical technology company that non-invasively measures, monitors, and manages fluid status and tissue composition using bioimpedance spectroscopy (BIS). ImpediMed produces a family of FDA cleared and CE Marked medical devices, including the SOZO® Digital Health Platform that is used to assess secondary lymphedema with a focus on breast cancer-related lymphedema. (PRNewsfoto/ImpediMed) Mr. Anderson brings to ImpediMed more than 16 years of experience in US hospital sales, health system account management, and the commercialization of innovative clinical technologies. His experience spans breast health, body composition and medical aesthetics, bringing direct commercial relevance across Impedimed's br
Show less
Read more
Impact Snapshot
Event Time:
HOLX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HOLX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HOLX alerts
High impacting Hologic, Inc. news events
Weekly update
A roundup of the hottest topics
HOLX
News
- Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health PortfolioBusiness Wire
- HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash [Yahoo! Finance]Yahoo! Finance
- Hologic (NASDAQ:HOLX) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Hologic Announces Financial Results for First Quarter of Fiscal 2026Business Wire
- Analysts consider potential Qiagen deal amid reported strategic review [Yahoo! Finance]Yahoo! Finance
HOLX
Earnings
- 1/29/26 - Miss
HOLX
Sec Filings
- 2/17/26 - Form SCHEDULE
- 2/12/26 - Form 4
- 2/6/26 - Form 8-K
- HOLX's page on the SEC website